Skip to main content
. 2006 Jan 26;65(9):1213–1218. doi: 10.1136/ard.2005.046797

Table 2 Number and frequency of methylenetetrahydrofolate reductase gene single‐nucleotide polymorphism genotypes in Causasians and African‐Americans with rheumatoid arthritis and controls.

SNP genotype African‐Americans with RA (n = 138) Caucasians with RA (n = 393) African‐American controls (n = 53) Caucasian controls (n = 50)
 677 CC 109 (0.79) 196 (0.50) 39 (0.75)* 25 (0.50)
 CT 27 (0.20) 157 (0.40) 12 (0.23) 22 (0.44)
 TT 2 (0.01) 40 (0.10) 1 (0.02) 3 (0.06)
rs2066462 CC 117 (0.85) 320 (0.81) 42 (0.79) 37 (0.74)
 CT 21 (0.15) 68 (0.18) 10 (0.19) 13 (0.26)
 TT 0 5 (0.01) 1 (0.02) 0
 1298 AA 102 (0.74) 178 (0.45) 36 (0.68) 25 (0.50)
 AC 35 (0.25) 165 (0.42) 16 (0.30) 19 (0.38)
 CC 1 (0.01) 50 (0.13) 1 (0.02) 6 (0.12)
rs4846051 TT 63 (0.46) 387 (0.98) 25 (0.47) 49 (0.98)
 TC 60 (0.43) 6 (0.02) 23 (0.43) 1 (0.02)
 CC 15 (0.11) 0 5 (0.09) 0
rs2274976 GG 123 (0.93) * 355 (0.90) 43 (0.84) * 46 (0.92)
 GA 9 (0.07) 37 (0.09) 8 (0.16) 4 (0.08)
 AA 0 1 (0.002) 0 0

RA, rheumatoid arthritis; SNP, single‐nucleotide polymorphism.

Caucasians with rheumatoid arthritis were from the Iowa rheumatoid arthritis cohort (n = 200),19 the University of Alabama at Birmingham folate trial in rheumatoid arthritis (n = 59)20 and the Immunex rheumatoid arthritis trial (n = 134).21 African‐Americans with rheumatoid arthritis were from the Grady African‐American Rheumatoid Arthritis (GAARA) cohort (n = 108),18 the aforementioned folate trial (n = 18) and Immunex trial (n = 12). *In all, 102 subjects from GAARA were genotyped at the rs2274976 GA SNP; 52 African‐American controls were genotyped at the 677 CT SNP and 51 subjects at the rs2274976 GA SNP.